EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 05:15 ET (22-Jun-2026 09:15 GMT/UTC)

Molecule found to drive skin cancer growth and evade immune detection

NYU Langone Health / NYU Grossman School of Medicine
Peer-Reviewed Publication

A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors’ ability to evade attack by the body’s immune system, a new study shows.

Journal: Cancer Discovery

Osimertinib ± savolitinib in MET-EGFR NSCLC trial

Maximum Academic Press
Peer-Reviewed Publication

A groundbreaking phase 2 clinical trial has unveiled promising advancements in the treatment landscape for non-small cell lung cancer (NSCLC), specifically targeting patients harboring epidermal growth factor receptor (EGFR) mutations alongside MET gene aberrations.

Journal: Nature Communications

DNA barcoding reveals the complexity of breast cancer liquid biopsies

Olivia Newton-John Cancer Research Institute
Peer-Reviewed Publication

DNA barcoding can be used to track cancer cells in solid and liquid biopsies, empowering future research into more reliable breast cancer diagnosis and treatment strategies.

Journal: Molecular Systems Biology
Funder: National Breast Cancer Foundation, National Health and Medical Research Council, Love Your Sister

Does a past abortion or miscarriage affect a woman’s risk of developing breast cancer?

Wiley
Peer-Reviewed Publication

A prior abortion or miscarriage was not linked with an increased risk of developing pre- or postmenopausal breast cancer in a study published in Acta Obstetricia et Gynecologica Scandinavica.

Journal: Acta Obstetricia Et Gynecologica Scandinavica

Could a treatment redirect the body’s anti-viral immune response to target cancer cells?

Wiley
Peer-Reviewed Publication

Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a major target of cancer immunotherapy. Unfortunately, drugs that target it do not trigger especially strong anti-cancer immune responses. New research published in Advanced Science reveals a promising strategy that harnesses pre-existing antiviral immunity to boost anti-tumor responses.

Journal: Advanced Science

Biomarkers predict patients with glioblastoma who will survive longer after treatment with cancer-targeting virus

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Glioblastoma is a deadly brain cancer that suppresses the immune system and doesn’t respond well to available therapies

Researchers engineered a cancer-targeting virus that can be injected directly in glioblastoma tumors

Adding an immune booster to the virus increased the length of survival in a subset of patients and helped identify blood biomarkers in patients most likely to benefit

Journal: Clinical Cancer Research

Growth of spreading pancreatic cancer fueled by 'under-appreciated' epigenetic changes

Johns Hopkins Medicine
Peer-Reviewed Publication

In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns Hopkins Medicine scientists report they have found that a gene called KLF5 (Krueppel-like factor 5) fuels the growth of such spreading tumors not by acquiring abnormal changes in the cancer cells’ DNA code itself but by altering chemical changes and organization of DNA, or epigenetics, that turns genes on and off

Journal: Molecular Cancer
Funder: National Institutes of Health, Celgene License Pathway Agreement, A gift from the friends and family of Jasmine Lampadarios.

University of South Alabama Research named Top 10 Scientific Breakthroughs of 2025

University of South Alabama
Grant and Award Announcement

Dr. Simon Grelet, with the University of South Alabama's Mitchell Cancer Institute, has identified a novel mechanism by which neurons transfer mitochondria — the cell’s energy-producing structures — to cancer cells. This interaction fuels cancer metastasis and opens new possibilities for therapeutic intervention.

UCalgary study investigates the use of a common vitamin to treat the aggressive brain cancer glioblastoma

University of Calgary
Peer-Reviewed Publication

University of Calgary researchers have designed a study to investigate whether high doses of vitamin B3 or niacin could rejuvenate compromised immune cells to kill glioblastoma tumour cells. The clinical trial was designed to determine the maximum dose and potential benefit of controlled-release niacin that could be added to the recommended chemotherapy and radiotherapy treatments.

Journal: Neuro-Oncology
Funder: Alberta Cancer Foundation, Canadian Institutes of Health Research

New nanoparticles enable melanoma tumors to be removed with low-power laser light

Oregon State University
Peer-Reviewed Publication

Researchers at Oregon State University have developed and tested in a mouse model a new type of nanoparticle that enables the removal of melanoma tumors with a low-power laser.

Journal: Advanced Functional Materials
Funder: Eunice Kennedy Shriver National Institute of Child Health and Human Development